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Abstract
Centrosome amplification is a hallmark of cancer, and centrosome
clustering is essential for cancer cell survival. The mitotic kinesin
HSET is an essential contributor to this process. Recent studies
have highlighted novel functions for intraflagellar transport (IFT)
proteins in regulating motors and mitotic processes. Here, using
siRNA knock-down of various IFT proteins or AID-inducible degra-
dation of endogenous IFT88 in combination with small-molecule
inhibition of HSET, we show that IFT proteins together with HSET
are required for efficient centrosome clustering. We identify a
direct interaction between the kinesin HSET and IFT proteins, and
we define how IFT proteins contribute to clustering dynamics
during mitosis using high-resolution live imaging of centrosomes.
Finally, we demonstrate the requirement of IFT88 for efficient
centrosome clustering in a variety of cancer cell lines naturally
harboring supernumerary centrosomes and its importance for
cancer cell proliferation. Overall, our data unravel a novel role for
the IFT machinery in centrosome clustering during mitosis in cells
harboring supernumerary centrosomes.
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Introduction
The centrosome is a dynamic organelle that has essential functions
in both cycling and non-cycling cells. In non-cycling cells, the
centrosome/basal body contributes to cell polarization, motility,
and primary cilia formation [1]. In dividing cells, centrosomes
contribute to the assembly of a functional bipolar mitotic spindle
[2,3]. Having only two centrosomes per mitotic cell is essential
for accurate chromosome segregation. Indeed, the presence of
supernumerary centrosomes, known as centrosome amplification,
promotes multipolar spindle formation that can drive chromosome
segregation errors and aneuploidy [4–8] resulting in tumorigenesis
initiation and/or acceleration [9–12]. Despite those pro-tumorigenic
effects, supernumerary centrosomes and multipolar spindles that
result in multipolar anaphases are, most of the time, detrimental for
cell proliferation and survival [4,7,8,13–16]. However, cancer cells
that often present high levels of centrosome amplification are
capable of clustering those centrosomes to favor the formation of
(pseudo)bipolar mitotic spindles. This process allows cancer cell
proliferation and survival [4,13,17]. Multiple studies have high-
lighted the importance of the mitotic checkpoint and the actin/
microtubule networks, together with their associated proteins and
motors, for efficient centrosome clustering [9,13,17,18]. Among
those microtubule-associated motors, the minus-end-directed
kinesin HSET/KIFC1 is of particular interest, since it is essential for
supernumerary centrosome clustering but not for the division of
cells with two centrosomes [9,13,19–21].
IFT proteins form polarized cargo transport complexes that func-
tion in both non-dividing and dividing cells in association with
microtubules and motors. They were originally described as large
molecular complexes transported by molecular motors along the
length of cilia and flagella, and they are essential for their assembly
and function [22–24]. IFT proteins are classified into two
complexes: IFT complex A and IFT complex B. Within the IFT B
complex, IFT88/70/52/46 subunits are part of the IFT-B core
subcomplex (IFT-B1 [25,26]).
In addition to their role in cilia, multiple studies recently showed
that IFT proteins also function outside of the ciliary compartment,
in a variety of cellular processes. Indeed, IFT proteins are important
for immunological synapse organization in non-ciliated lymphocytes
[27] and for interphase microtubule cytoskeleton organization and
dynamics [28–30]. IFT proteins also contribute to multiple aspects
of cell division. In prometaphase, IFT88 contributes to NuMA accu-
mulation at k-fiber minus ends, favoring their incorporation into the
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mitotic spindle and contributing to proper chromosome alignment
[31]. In cytokinesis, an IFT-B subcomplex made of IFT88/70/52/46
directly interacts with the kinesin MKLP2, regulates the relocaliza-
tion of Aurora B to the spindle midzone, and subsequently shapes
central spindle microtubule architecture [32]. Finally, IFT88 in
complex with cytoplasmic dynein 1 contributes to the relocalization
of peripheral microtubule clusters toward the spindle poles to
ensure the proper formation of astral microtubule arrays and correct
spindle orientation [33].
Similarities between this latter mechanism and the process of
centrosome clustering, per se, led us to hypothesize that IFT
proteins could contribute to centrosome clustering in cells harboring
supernumerary centrosomes. We also hypothesized that this activity
of IFT proteins could be mediated by their interaction with micro-
tubule-associated motors involved in this process, such as dynein or
the kinesin HSET/KIFC1.
Here, we establish that proteins of the IFT-B subcomplex are
required for centrosome clustering. Using siRNA knock-down of
various IFT proteins or auxin-inducible degradation of endogenous
IFT88 in combination with small-molecule inhibitors, we show the
functional contribution of IFT proteins together with both HSET and
dynein to the process of centrosome clustering. Moreover, we iden-
tify a direct interaction, in vitro, between the kinesin HSET and IFT-
B subcomplex proteins. Taking advantage of high-resolution imag-
ing of centrosome dynamics, we also show that IFT52 knock-down
decreases centrosome clustering dynamics, both in late G2 and in
mitosis, to the same extent as HSET small-molecule inhibition. This
result suggests a role for IFT proteins in centrosome clustering
through the modulation of mitotic motors. Finally, we demonstrate
the importance of IFT88 and IFT52 for efficient centrosome cluster-
ing in cancer cell lines naturally harboring supernumerary centro-
somes and the importance of IFT88 for cancer cell proliferation.
Overall, our data unravel a novel role for the IFT machinery in
centrosome clustering during mitosis in cells harboring supernumer-
ary centrosomes.
Results and Discussion
IFT88 and IFT52 are required for centrosome clustering
Previous studies have shown that members of the IFT-B subcomplex
such as IFT88 could interact with and/or modulate motors during
mitosis including dynein 1 [33] or MKLP2 [32]. In order to test
whether IFT proteins are involved in centrosome clustering, we
depleted various IFT proteins from RPE-1 cells with supernumerary
centrosomes. In these cells, supernumerary centrosomes were
generated by overexpressing the kinase Plk4 under the control of a
doxycycline-inducible system (Fig EV1A; [34]). We observed that
both IFT52 and IFT88 decorate the mitotic spindle poles in the cells
(Figs 1A and EV1B). To assess the impact of IFT protein depletion
on centrosome clustering, we quantified the occurrence of multipo-
lar anaphases using live-cell analysis (Fig 1B and C, Movies EV1
and EV2). We found that while siRNA depletion of IFT27 did not
affect the proportion of cells undergoing multipolar anaphases,
depletion of either IFT88 or IFT52 induced a twofold increase
(10.8% in siCT versus 21.6 and 22.8% for siIFT88 and siIFT52,
respectively) in the proportion of cells undergoing multipolar
anaphases compared to control siRNA-transfected cells (Fig 1D and
E). Importantly, the defects observed upon depletion of human
IFT52 were rescued by re-expressing mouse IFT52 in IFT52-depleted
cells, validating the specificity of the siRNA (Figs 1E and EV1C).
Similar results were obtained in a different RPE-1 cell line overex-
pressing Plk4 as described above and in which DNA content was
visualized using H2B-EGFP instead of SiR-DNA staining to label the
DNA (Fig EV1D and E). To assess whether IFT52 and IFT88, which
belong to the same subcomplex of IFT-B [25], function together in
the process of centrosome clustering, we performed the co-depletion
of IFT88 and IFT52 (Fig EV1F and G). The level of multipolar
anaphases observed after co-depletion was not significantly different
from single IFT protein depletion. This result confirms that IFT88
and IFT52 are most likely acting together in the process of centro-
some clustering. In order to control that IFT protein depletion does
not affect the mitotic spindle or centrosome integrity, we analyzed
immunofluorescence images of RPE-1 cells. No significant global
defects in spindle organization were observed upon IFT protein
depletion in cells with or without centrosome amplification
(Fig EV1H). Indeed, IFT protein depletion by itself was not sufficient
to induce multipolar spindle formation in mitotic cells without
centrosome amplification (Fig EV1I). Moreover, IFT protein deple-
tion did not weaken centriolar cohesion within the centrosomes.
Indeed, the proportion of spindle pole with less than two centrioles
remained unchanged (Fig EV1J and K). Finally, defects in astral
microtubules described in other cell lines, such as LLC-PK1 [33],
were also observed in RPE-1 cells with no centrosome amplification
(Fig EV1H, upper panels).
Then, to achieve a complete depletion of IFT proteins in cells
using an alternative approach, we targeted both endogenous alleles
of IFT88 in DLD-1 cells with an auxin-inducible degron (AID) that
triggers rapid depletion of the tagged protein upon auxin addition
[35,36]. Complete depletion of IFT88 was achieved following auxin
addition to the culture medium (Fig 1F and G). Centrosome amplifi-
cation was achieved by doxycycline-induced Plk4 kinase overex-
pression (Figs 1H and EV1A and EV2A). Complete depletion of
IFT88 induced a 30% increase in the proportion of multipolar
anaphases in DLD-1 cells with centrosome amplification (28.2% in
CT versus 42.9% in auxin condition, Fig 1I and J; Movies EV3 and
EV4). Similar results were obtained in DLD-1 cells and tetraploid
HCT-116 cells harboring supernumerary centrosomes in which
IFT88 was depleted using siRNA (Fig EV2B–E). This further vali-
dated the importance of IFT proteins for efficient clustering in a vari-
ety of cell lines. Of note, as described for RPE-1 cells, acute IFT88
depletion upon auxin addition did not affect global spindle architec-
ture or centriolar cohesion and did not trigger multipolar mitosis in
mitotic cells with no centrosome amplification (Fig EV2A, F and G).
Altogether, these results indicate that IFT52 and IFT88 are neces-
sary for efficient clustering of supernumerary centrosomes in a vari-
ety of cell types.
IFT52 and IFT88 act in association with dynein and HSET for
efficient centrosome clustering
Dynein and the kinesin HSET/KIFC1 are two of the main mitotic
motors involved in centrosome clustering [13,17]. Moreover, recent
studies showed that IFT proteins function together with mitotic
motors [32,33] or can even control kinesin activity in vitro [37]. To
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Figure 1. IFT proteins contribute to centrosome clustering.
A Immunofluorescence images of a mitotic RPE-1 cell, with centrosome amplification, showing IFT52 localization. Magnified boxes, spindle poles. Scale bar in magnified
box, 1 lm.
B Schematic of experimental timeline for RPE-1 cells used in panels (B–E).
C Representative still images extracted from a movie of RPE-1 cells, labeled with SiR-DNA. siRNA treatments are indicated.
D Immunoblots showing IFT proteins depletion 30 h after siRNA treatment in RPE-1 cells. GAPDH, loading control.
E Quantification of the percentage of multipolar anaphases following the indicated siRNA treatment. Mean  SEM from a minimum of four independent experiments.
****P < 0.0001; ***P < 0.001; ns: non-significant; unpaired t-test. For each condition, a minimum of 600 cells were quantified.
F Immunofluorescence images of DLD1 cells expressing endogenous IFT88-AID-YFP. IFT88 was labeled using an anti-GFP antibody to show its depletion from centrioles
after auxin treatment. Scale bar in magnified box, 2 lm.
G Immunoblots showing endogenous IFT88-AID-YFP depletion in DLD-1 cells following various times of auxin treatment.
H Schematic of experimental timeline for DLD-1 cells used in panels (H–J).
I Representative still images extracted from a movie of DLD-1 cells with supernumerary centrosomes, expressing H2B-EGFP and treated with or without auxin (Aux) in
order to degrade endogenous IFT88 tagged with AID.
J Quantification of the percentage of multipolar anaphases in DLD-1 IFT88-AID following the indicated treatments. CT: control condition; Aux: auxin treatment.
Mean  SEM from three independent experiments. **P < 0.01; unpaired t-test. For each condition, a minimum of 373 cells were quantified.
Source data are available online for this figure.
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test whether those motors function together with IFT52 to mediate
centrosome clustering, we used small-molecule inhibitors of dynein
or HSET in combination with the depletion of IFT52. As expected,
the use of ciliobrevin D, a small-molecule inhibitor of the AAA+
ATPase activity of dynein [38], at 20 lM, resulted in a twofold
increase in the proportion of multipolar anaphases in RPE-1 cells
with supernumerary centrosomes (11.8% in DMSO control condition
versus 22.3% in ciliobrevin-treated condition). This result was simi-
lar to the effects of IFT52 depletion in those cells (22.9%, Fig 2A–C).
Importantly, combining IFT52 depletion and dynein inhibition did
not increase the proportion of multipolar anaphases, compared to
single perturbation. This result suggested that IFT88 and dynein
could function together in centrosome clustering. Similarly, the use
of 25 lM of the allosteric inhibitor of the kinesin HSET, CW069 [39],
resulted in an increased proportion of multipolar anaphases similar
to the increase observed with IFT52 depletion (21.8% versus 22.9%,
respectively, Fig 2A). Importantly, combining HSET inhibition and
IFT52 depletion did not lead to cumulative defects, suggesting that
IFT52 and HSET could function together to facilitate centrosome
clustering in RPE-1 cells with supernumerary centrosomes. To con-
firm this observation in RPE-1 cells using an alternative approach,
we used a combination of siRNA targeting both IFT52 and HSET
(Fig EV2H and I). As expected, the strong depletion of HSET
achieved using siRNA led to a sixfold increase compared to the
control condition. Importantly, co-depletion of IFT52 and HSET did
not significantly change the level of multipolar anaphases compared
to the single depletion of HSET (Fig EV2I). This confirmed that
IFT52 and HSET could function together in centrosome clustering.
Taking advantage of the auxin-inducible degradation, we also
tested whether IFT88 could function in association with motors to
allow centrosome clustering. To exclude that the mitotic defects
observed could result from a prolonged depletion of IFT proteins
in interphase, we arrested cells in mitosis at the metaphase/
anaphase transition and induced the degradation of IFT88-AID
with auxin. To arrest cells at the metaphase/anaphase transition,
we used two small molecules, APCIN and proTAME, to synergisti-
cally block APC/C-Cdc20 interaction (Fig 2B–E) [40]. Using
immunofluorescence experiments to quantify mitotic cells with
unclustered centrosomes, we found that auxin treatment triggered
a 30% increase in the proportion of cells with unclustered centro-
somes, compared to control-treated cells (38.8% in CT versus
59.3% in auxin, Fig 2F). As described above in RPE-1 cells, treat-
ments with ciliobrevin D (50 lM) or CW069 (150 lM) led to an
increase in DLD-1 cells with unclustered centrosomes similar to
the increase observed with IFT88 depletion. Again, no cumulative
effect on the proportion of unclustered centrosomes was observed
when combining IFT88 acute depletion with either dynein or HSET
inhibition (Fig 2E and F). Overall, these results suggest that, as
described above for IFT52, IFT88 is likely to act together with
dynein and HSET to mediate efficient centrosome clustering. Of
note, the effect observed on centrosome clustering using DLD-1
cells and auxin-inducible degradation of IFT88 cannot be due to
impaired cilia-dependent signaling following IFT perturbation
because DLD-1 cells do not grow cilia [41]. Moreover, cells are
arrested in mitosis for 2 h and acutely depleted of IFT88 in mito-
sis, using the AID system. In this experiment, IFT88 depletion only
occurs in mitosis, where cilia are absent, therefore precluding any
cilia-dependent perturbation.
IFT88/70/52/46 subcomplex directly interacts with HSET,
and depletion of IFT88 reduces HSET turnover on mitotic
spindle microtubules
IFT proteins were previously reported to function with dynein 1 in
mitosis [33]. To further understand whether and how IFT proteins
could function with the kinesin HSET during centrosome clustering,
we assessed whether a subcomplex of IFT proteins including IFT52
and IFT88 (Fig 3A) could interact biochemically with HSET. We first
used endogenous co-immunoprecipitation assays from MDA-MB-231
cell lysate, a cancer cell line naturally harboring supernumerary
centrosomes [4], and found that IFT88 co-immunoprecipitated with
HSET. This result indicates an endogenous interaction between the
two proteins in cell lysates (Fig 3B). To further validate this interac-
tion, we next expressed and purified, from insect cells, recombinant
full-length (FL) GFP-HSET protein as well as the tail (Ta) and motor
(Mot) domains of HSET fused to GFP (Fig 3C and D) and performed
GFP-TRAP pull-down assays. Using FL GFP-HSET, we pulled down
both IFT88 and IFT52 from mitotic MDA-MB-231 cell lysate (Fig 3E)
confirming the interaction between the motor and IFT proteins in
the cell lysate. Then, using a purified recombinant IFT-B subcom-
plex made of IFT88/70/52/46 (Fig 3A) we found that this interac-
tion is direct as FL GFP-HSET can pull-down the IFT-B subcomplex
in vitro (Fig 3F). To further identify the interaction domain of this
IFT-B subcomplex on the motor, we then used either FL or truncated
GFP-HSET to pull-down recombinant IFT proteins. Both FL and
motor GFP-HSET interacted with IFT88 but not the tail domain
(Fig 3G). This shows that the HSET/IFT protein interaction site is
within the motor domain of HSET. We finally confirmed this inter-
action, using the motor domain truncation of HSET (aa 145–673;
Fig 3C) to pull-down endogenous IFT proteins from MDA-MB-231
cell lysate (Fig 3H). In this context, HSET motor domain truncation
pulled down IFT52 and IFT88 further validating the interaction.
However, it did not pull-down IFT27, suggesting either that there is
no interaction between IFT27 and HSET or that the amount of IFT27
pulled down is below detection level. The lack of interaction is
consistent with the absence of effects of IFT27 depletion on multipo-
lar anaphases observed in Fig 1E. Moreover, HSET motor domain
truncation did not interact with IFT-A protein IFT140. This suggests
that only a subset of the IFT machinery, including IFT52 and IFT88,
interacts with HSET to promote centrosome clustering.
To assess whether the HSET/IFT protein interaction could affect
the motor behavior, we then performed fluorescence recovery after
photobleaching (FRAP) experiments. To monitor GFP-HSET turn-
over on mitotic spindle microtubules upon IFT88 depletion,
GFP-HSET was introduced in an isogenic manner in the DLD-1
IFT88-AID cell line, described in Fig 1. As expected, GFP-HSET
localized to spindle microtubules (Fig 3I). Importantly, depletion of
IFT88 upon auxin addition or HSET inhibition did not affect HSET
levels on the mitotic spindle before photobleaching (Fig EV3A). We
thus performed FRAP experiments of GFP-HSET and analyzed its
recovery along the mitotic spindle (Fig 3I and J). Upon IFT88 deple-
tion (auxin-treated cells), we observed a 15% decrease in the maxi-
mum recovery of GFP-HSET on the mitotic spindle compared to
control-treated cells (46.6% versus 55.7%, respectively). This effect,
which was comparable to the decrease in recovery observed upon
HSET inhibition with CW069, indicates that IFT88 depletion reduces
GFP-HSET turnover on mitotic spindle microtubules.
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IFT52 depletion reduces centrosome clustering dynamics in late
G2 and mitosis
Given that IFT proteins depletion results in a reduced clustering of
supernumerary centrosomes and a reduced HSET motor recovery
on microtubules following photobleaching, we next assessed the
impact of IFT proteins depletion on the dynamics of centrosomes.
We took advantage of the fact that the doxycycline-inducible Plk4
RPE-1 cells (used in Fig 1) also carried a centrin-GFP marker [34],
and we imaged these cells with a high temporal resolution. In this
experiment, the centrin signal corresponds to centrosomes made of
a pair of centrioles (Fig EV3B). Using Imaris software, we
established the 3-dimensional trajectories of centrosomes over time
and extracted parameters on their dynamics. These parameters
included individual centrosome speed and inter-centrosomal
distance. We analyzed centrosome trajectories from the point
where all supernumerary centrosomes behaved as independent
entities (last centrosome separation, blue arrows, Fig 4A, Movies
EV5 and EV6) up to anaphase onset. This observation time was
divided into two periods: the period from the last centrosome
separation to nuclear envelope breakdown (NEB), which corre-
sponds to late G2/prophase, and the period from NEB to anaphase
onset. Measures of the duration of those two periods showed that
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Figure 2. IFT proteins contribute to centrosome clustering in association with the mitotic motors HSET and dynein.
A Quantification of the percentage of multipolar anaphases following a combination of siRNA treatment and small-molecule inhibition of dynein (ciliobrevin D: Cilio) or
HSET (CW069: CW). Mean  SEM from a minimum of three independent experiments. ****P < 0.0001; *P < 0.05; ns: non-significant; unpaired t-test. For each
condition, a minimum of 600 cells were quantified.
B Schematic of experimental timeline for DLD-1 cells used in panels (C–F). Cells were arrested at metaphase-to-anaphase transition using proTAME and APCIN APC/C
inhibitors. Cells were also treated with or without auxin in combination with small-molecule inhibitors.
C Representative immunofluorescence image of DLD-1 cells with supernumerary centrosomes in control condition. Scale bar in magnified box, 2 lm.
D Representative immunofluorescence image of DLD-1 cells with supernumerary centrosomes and depleted of endogenous IFT88-AID-YFP upon auxin addition. Scale
bar in magnified box, 2 lm.
E Immunoblots showing endogenous IFT88-AID-YFP depletion upon auxin treatment combined or not with small-molecule inhibitors.
F Quantification of the percentage of unclustered centrosomes following combination of auxin treatment and small-molecule inhibition of dynein (Cilio, left panel)
or HSET (CW, right panel). Mean  SEM from a minimum of three independent experiments. **P < 0.01; ns: non-significant; unpaired t-test. For each condition,
a minimum of 233 cells were quantified.
Source data are available online for this figure.
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Figure 3. IFT 88/70/52/46 complex directly interacts with HSET, and depletion of IFT88 reduces HSET turnover on mitotic spindle microtubules.
A Schematic representing the core of IFT-B subcomplex. Adapted from [Ref. 26], with the permission of Cold Spring Harbor Laboratory Press, © 2016. IFT proteins
depicted in colors are the one for which an interaction with HSET was tested and confirmed in the following experiments (panels B–H).
B Immunoblots of endogenous immunoprecipitation of HSET from mitotic MDA-MB-231 cell lysate.
C Schematic of various forms of recombinant full length (FL), motor domain (Mot), and tail domain (Ta) of GFP-HSET used in panels (D–H).
D Coomassie blue staining of the purified recombinant GFP-HSET proteins bound to GFP-trap beads as used in panels (E–H).
E Immunoblots of a pull-down done with FL GFP-HSET and endogenous IFT proteins from a mitotic cell lysate of MDA-MB-231 cells. B: GFP-Trap beads alone.
FL: GFP-Trap beads loaded with FL GFP-HSET.
F Immunoblots of a pull-down done with FL GFP-HSET and a purified recombinant IFT complex made of IFT88, IFT70, IFT52, and IFT46.
G Immunoblots of pull-downs done with FL, Ta, and Mot recombinant GFP-HSET, and recombinant IFT complex made of IFT88, IFT70, IFT52, and IFT46. B: GFP-Trap
beads alone. FL: GFP-Trap beads loaded with FL GFP-HSET. Mot: GFP-Trap beads loaded with motor GFP-HSET. Ta: GFP-Trap beads loaded with tail GFP-HSET.
H Immunoblots of pull-downs done with Mot GFP-HSET from a mitotic cell lysate of MDA-MB-231 cells. B: GFP-Trap beads alone. Mot: GFP-Trap beads loaded with
motor GFP-HSET.
I Representative still image of a FRAP experiment done on DLD-1 cells with endogenous IFT88 tagged with AID expressing GFP-HSET and treated with or without
auxin. The green box corresponds to the photobleached area. Scale bar in magnified box, 1 lm.
J Left: Quantification of the fluorescence recovery after photobleaching of GFP-HSET in DLD-1 cells following the indicated treatments. Mean  SEM of four
independent experiments. The green box represents the photobleaching period during the experiment. Right: Average recovery on the 15- to 20-s time period
highlighted in orange on the curves (left). Mean  SEM. **P < 0.01; unpaired t-test. For each condition, a minimum of 26 FRAP experiments were done.
Source data are available online for this figure.
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compared to control conditions (106 min in siCT versus 165 in
si52; Fig 4B). Inhibition of HSET using CW069 had a less
pronounced effect on the duration of this first period and was not
statistically significant (Fig 4B). Similarly, during the NEB to
anaphase onset period the results showed that only IFT52 deple-
tion induced a delay (45 min in siCT versus 53.5 min in si52
condition). In parallel, we measured the average velocity of indi-
vidual centrosome during these two periods (Fig 4C). During the
last centrosome separation to NEB period, we found that both
IFT52 depletion (0.347 lm/min versus 0.384 lm/min in siCT) and
HSET inhibition (0.347 lm/min versus 0.375 lm/min in DMSO)
reduced centrosomes velocity compared to controls. This was not
the case in the NEB to anaphase onset period upon IFT52 deple-
tion or HSET inhibition. This effect on centrosome velocity was
not due to a modification of microtubule dynamics as IFT52 deple-
tion did not affect microtubule dynamics monitored by tracking
EB1 comet velocity (Fig EV3C). To dynamically quantify the
impact of IFT52 and HSET on centrosome clustering, we next stud-
ied if IFT52 depletion or HSET inhibition resulted in an increased
distance between clustered centrosomes. We measured the mini-
mal distance between adjacent centrosomes that would eventually
be clustered together at anaphase onset: “d” in Fig 4D, as opposed
to distance “D” which is the minimal distance between two centro-
somes that end up unclustered at anaphase onset (Fig 4D and
Movie EV7). We found that both IFT52 depletion and HSET inhibi-
tion resulted in an increased distance between the closest centro-
somes during the observation period: last 30 min before NEB up
to 50 min after NEB (50 min is the average time of anaphase onset
for the four conditions). More specifically, at 50 min (black arrow-
head Fig 4D), we observed a 20% increase in this distance for si52
versus siCT conditions (3.9 lm versus 3.1 lm) and a 24%
increase between CW069 and DMSO conditions (4.2 lm versus
3.2 lm). This increase in inter-centrosomal distance correlates
with the increase in multipolar anaphases observed in the same
cells with similar treatments (Fig 1). Collectively, the data on
centrosome dynamics indicate that IFT52 depletion results in
an increased distance between centrosomes in mitosis that corre-
lates with an increased proportion of multipolar mitotic figures in
anaphase.
Cancer cells with natural centrosome amplification rely on IFT88
for efficient clustering and proliferation
Having demonstrated that a subset of IFT proteins contributes to the
clustering of supernumerary centrosomes generated by the overex-
pression of Plk4 kinase or by cell tetraploidization (Figs 1 and EV1
and EV2), we assessed if IFT proteins were also necessary for
centrosome clustering in cells naturally harboring supernumerary
centrosomes. Cancer cells frequently harbor supernumerary centro-
somes, so we screened the level of centrosome amplification in four
different cancer cell lines: 786-0, renal adenocarcinoma cells (18.3%
centrosome amplification); HT-29, colorectal adenocarcinoma cells
(19.3% amplification); MDA-MB-231, breast adenocarcinoma cells
(27.1% amplification); and Caco-2, colorectal adenocarcinoma cells
(36.6% amplification; Figs 5A and B, and EV3E). Then, we quanti-
fied the proportion of unclustered centrosomes in mitosis, in those
cells, following IFT88 depletion (Fig 5C and D). We found that in all
four cell lines, depletion of IFT88 led to an increased proportion of
unclustered centrosomes (786-O, 40.8% siCT versus 58.8% si88;
HT-29, 43.7% versus 69.7%; MDA-MB-231, 43.3% versus 66.2%;
and Caco-2, 52.5% versus 81.1%). This result indicates that in cells
naturally harboring supernumerary centrosomes, IFT88 is also
required for efficient centrosome clustering. Importantly, depletion
of IFT52 also results in an increased proportion of unclustered
centrosomes in Caco-2 cells, a phenotype that was rescued by re-
expressing mouse IFT52 (Figs 5E and EV3D). To control that the
perturbation of centrosome clustering resulted in multipolar
anaphases, we took advantage of a MDA-MB-231 cell line express-
ing H2B-EGFP and analyzed live mitosis in binucleated cells
(Fig 5F–H). These binucleated cells, likely generated after cytokine-
sis failure, are naturally present in the cell population. Of note, these
binucleated cells naturally harbor a higher percentage of supernu-
merary centrosomes compared to the rest of the population, which
is mononucleated. Indeed, 67.1% of those binucleated cells have
supernumerary centrosomes compared to 27.1% when considering
all cell types in the MDA-MB-231 cell population (Fig 5A). Upon
IFT88 depletion the proportion of multipolar anaphases in binucle-
ated cells went from 12.1 to 37.2%, clearly indicating that IFT88
depletion was triggering multipolar anaphases. Multipolar
▸Figure 4. IFT52 depletion reduces centrosome clustering dynamics in late G2 and in mitosis.A Representative still images of a movie depicting centrosome movement around the nucleus in late G2 and around the condensed chromosomes in mitosis. Top row:
raw microscopic images. Bottom row: segmented volumes, spots, and spot tracks generated in Imaris (Bitplane). The blue arrows indicate the last two centrosomes of
the cells that separate from each other and that start to move independently. NEB: nuclear envelope breakdown. Ana: anaphase. Numbers indicate the time in
minutes.
B Quantification of the duration from last centrosome separation to NEB period (left diagram) and from NEB to anaphase onset period (right diagram) in individual
cells following the indicated treatments. Red bars: mean of a minimum of three independent experiments. ns: non-significant; **P < 0.01; *P < 0.05; ns: non-
significant; unpaired t-tests. For each condition, a minimum of 24 cells were analyzed.
C Quantification of the average individual centrosome speed from the last centrosome separation to NEB period (left diagram) and NEB to anaphase onset period (right
diagram) following the indicated treatments. Red bars: mean of three independent experiments. ****P < 0.0001; **P < 0.05; ns: non-significant; unpaired t-tests. For
each condition, a minimum of 192 centrosome tracks were analyzed.
D Left panel, still images of a movie representing an RPE-1 cell with supernumerary centrosomes going through anaphase. In this experiment, we quantify the minimal
distance between centrosomes that cluster together and move with a DNA mass at anaphase onset (d). We do not quantify the distance between centrosomes that
move with different DNA mass (D). Numbers indicate the time in minutes. Right panel, quantification over time of the minimal distance between two adjacent
centrosomes, in centrosomes that are clustered together at anaphase onset (d), following the indicated treatments. Mean  SEM from a minimum of three
independent experiments. The mean value for a specific time point is the centered moving average of three consecutive data, centered on the specific time point. For
each condition, a minimum of 141 inter-centrosome distance tracks were analyzed. Gray arrowhead indicates a transient increase in the minimal centrosome-
to-centrosome distance in CW and si52 conditions following NEB. Black arrowhead indicates the increased minimal centrosome-to-centrosome distance upon CW
and si52 treatments compared to DMSO and siCT conditions at the average time of anaphase onset. Dashed line indicates the time of NEB.
◀
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anaphases are known to result in severe aneuploidy and cell death
in the following cell cycles [4]. Therefore, we then tested how IFT88
depletion was affecting MDA-MB-231 cell proliferation over the
course of 9 days (Fig 5I and J). We found that IFT88 depletion
significantly reduces cell proliferation starting from day three and
up to day nine. In an alternative way to test cell growth perturba-
tion, we performed clonogenic assays with the MDA-MB-231 cells
and we found that depletion of IFT88 results in a twofold decrease
in the ability of the cells to form clones (Fig 5K). Similar defects on
clonogenic properties were also observed in cancer cells, in which
supernumerary centrosomes were induced either by tetraploidiza-
tion (HCT-116) or Plk4 overexpression (DLD-1), following knock-
down of IFT88 (Figs EV1A and EV2B–E and EV3F–I).
Overall, we show here that a subset of IFT proteins contributes
to centrosome clustering through their interaction with the mitotic
motors dynein, previously identified to interact with IFT proteins
[33], and with HSET (Figs 1–3 and EV4A). Detailed analysis of
centrosome dynamics following IFT proteins perturbation also
revealed that IFT proteins impact these dynamics starting from late
G2/prophase, in part through their interaction with the kinesin
HSET (Figs 4 and EV4B). At anaphase onset, IFT52 contributes to
the maintenance of a close distance between supernumerary centro-
somes that have to be clustered at the pole. Thus, at this stage, the
absence of IFT52 weakens centrosome clustering, a defect that even-
tually results in an increase in multipolar anaphases (Figs 1, 2, 4
and EV4C).
Altogether, these data introduce IFT proteins as new players in
the regulation of centrosome dynamics in mitosis by showing that
IFT52 is required to maintain a close distance between supernumer-
ary centrosomes. We observed a delay in mitotic progression (last
centrosome separation to NEB and NEB to anaphase onset) in
IFT52-depleted condition but not with CW069 perturbation. This
delay could result from a delay in the assembly of the mitotic spin-
dle. Indeed, IFT88 depletion was recently shown to be necessary for
the timely insertion of the newly generated k-fiber minus ends into
the mitotic spindle and for proper chromosome alignment [31].
Therefore, because IFT52 is essential for the stability of the IFT-B
subcomplex that includes IFT88 [25,42], it is possible that its deple-
tion also triggers delays in spindle assembly and chromosome align-
ment which eventually results in an increased mitotic progression
duration. This delay in spindle assembly, which is a dynamic event,
does not impact the global spindle morphology observed in
immunofluorescence images of the RPE-1 cells (Fig EV1). The
observation that the simultaneous IFT52 depletion and HSET inhibi-
tion do not affect centrosome speed observed during NEB to
anaphase onset period indicates that HSET is not, at this stage, the
dominant force in generating centrosome speed. However, the
increase in inter-centrosomal distance, observed with the same
perturbations, during the same mitotic period, indicates that HSET
is still important for centrosome clustering. Interestingly, the range
of distance measured between centrosomes that are clustered at
anaphase onset (from 5.6 lm at NEB to 3.1 lm at anaphase onset)
is within the range of distance where the kinesin HSET is acting
through its motor activity to promote centrosome clustering, as
recently demonstrated in MCF10a cells [20]. Finally, monitoring of
centrosome dynamics also revealed a sharp and transient increase
in the inter-centrosomal distance following NEB in the perturbed
conditions (gray arrowhead Fig 4D). This peak in the inter-centro-
somal distance upon NEB could result from the loss of centrosome
attachment to the nuclear envelope mediated by dynein [43] or
CENP-F [44] which is not counteracted by HSET activity when it is
perturbed in si52 and CW069 conditions. This analysis therefore
shows that dynein and HSET have complementary activities in the
positioning of centrosome at mitosis onset and that HSET, together
with IFT proteins, is essential to maintain centrosome cohesion at
NEB when the link between centrosomes and the nuclear envelope
mediated by dynein is lost (Fig EV4B). Overall, this work brings
novel insights on the dynamics of centrosome movements during
mitosis.
Centrosome clustering and centrosome dynamics are highly
dynamic events that require a robust machinery to function properly
[13,20]. Mechanistically, we show that IFT proteins are required for
◀ Figure 5. Cancer cells naturally harboring supernumerary centrosomes depend on IFT proteins for efficient centrosome clustering and proper proliferation.A Quantification of “natural” centrosome amplification in various mitotic cancer cell lines. For 786-O, HT-29, MDA-MB-231, and Caco-2 cells, the mean  SEM from 4
independent experiments is represented and a minimum of 485 cells were analyzed. For MDA-MB-231 binucleated cells, the means  SEM from four independent
experiments are represented, and 100 binucleated cells within the general MDA-MB-231 cell population were analyzed.
B Immunofluorescence images of mitotic figures of HT-29 colorectal cancer cells with normal and abnormal centrosome numbers. Scale bar in magnified box, 1 lm.
C Immunoblots of various colorectal cell lysates upon IFT88 depletion.
D Quantification of unclustered centrosomes figures in cells with centrosome amplification upon control or IFT88 depletion. MDA-MB-231 and Caco-2 cells were treated
with MG132 for 2 h in order to enrich for clustered centrosomes both in control and si88 conditions. Mean of three independent experiments  SEM. **P < 0.01;
*P < 0.05; unpaired t-test. For each condition, a minimum of 150 cells were quantified.
E Quantification of cells with unclustered centrosomes in Caco-2 cells with centrosome amplification upon control or IFT52 depletion. Cells were treated with MG132
for 2 h in order to enrich for clustered centrosomes both in control and si52 conditions. Mean of three independent experiments  SEM. ***P < 0.001; **P < 0.01;
unpaired t-test. For each condition, a minimum of 150 cells were quantified.
F Quantification from live analysis of multipolar anaphases in binucleated MDA-MD-231 cells. Mean of a minimum of three independent experiments  SEM.
**P < 0.01; unpaired t-tests. A minimum of 60 mitosis of binucleated cells were analyzed for each condition.
G Schematic of experimental timeline on MDA-MB-231 used for binucleated analysis. Cells were treated with siCT or si88 overnight. The quantification of multipolar
anaphases was done only on binucleated cells.
H Representative images from a time lapse of binucleated MDA-MB-231 cells treated or not with a siRNA against IFT88.
I Immunoblots of MDA-MB-231 cell lysate up to 9 days after siRNA depletion. Tub: tubulin; loading control.
J Quantification of the change in cell number in MDA-MB-231 cells along 9 days in si88 and siCT conditions. Mean of six independent experiments  SEM. **P < 0.01;
*P < 0.05; unpaired t-tests.
K Left panel, quantification of the clonogenic capabilities of MDA-MB-231 cells in siCT and si88 conditions. siCT is normalized to 100%. Mean of four independent
experiments done in duplicates  SEM. **P < 0.01; unpaired t-tests. Right panel, representative images of the clonogenic assays stained with crystal violet.
Source data are available online for this figure.
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both processes in part through their interaction with HSET. Of note,
IFT88 depletion recapitulates the effect of HSET inhibition, with
CW069, regarding its recovery on microtubules (Fig 3I and J).
CW069 inhibits the ATPase activity of HSET [39], and it is known
that ATP hydrolysis is required for the conformational change in the
neck domain responsible for the power stroke of kinesin-14 motors
such as HSET. This conformational change induces the subsequent
release of the motor head from the microtubule [45–47] resulting in
a reduced turnover of HSET on the microtubule. The similarity
between the chemical inhibition and IFT88 depletion regarding
HSET recovery in the FRAP experiment suggests that IFT88 binding
to HSET could impact the bio-mechanical capabilities of HSET. Kine-
sins can be autoinhibited due to the interaction between their motor
domain and tail domain [48]. This inhibition can be released
through the binding of a partner protein as shown for kinesin 1
motor [49]. Conversely, kinesin 14 family member KCPB, a plant
kinesin related to HSET, is known to be inhibited by the regulating
partner protein KIC [50]. Considering those regulatory mechanisms
of kinesins by partner proteins, it is possible that IFT proteins can
activate HSET by competing with inhibiting regulators of HSET
motor or through the release of an autoinhibition. This latter mecha-
nism is strongly supported by a recent study showing the activation
of kinesin 2, in vitro, by an IFT-B subcomplex proteins containing
IFT46-IFT52-IFT70-IFT88 [37]. Elucidating the role of IFT proteins
in regulating the activity of HSET will be the aim of future works.
This will include a thorough in vitro biochemical study in order to
reveal whether and how each individual IFT protein and/or
subcomplexes of IFT proteins interact with specific HSET domains
and to understand how these interactions affect HSET motor binding
and motor activities on microtubules.
Finally, we show that cancer cells naturally harboring supernu-
merary centrosomes are also dependent on IFT proteins for their
sustained proliferation (Fig 5). Therefore, elucidating if and poten-
tially how IFT proteins directly regulate the kinesin HSET or other
mitotic motor activities will be of particular interest for future stud-
ies. Indeed, the characterization of a novel regulatory interaction
of HSET may provide the required knowledge for the development
of novel therapeutic strategies, as perturbation of this interaction
should selectively target and kill cancer cells with supernumerary
centrosomes.
Materials and Methods
Cell lines and cell culture conditions
Cells were maintained at 37°C in a 5% CO2 atmosphere. Human
telomerase-immortalized retinal pigment epithelial (RPE-1) cells
were cultured in DMEM/F-12 (1:1) medium supplemented with
10% FBS, 100 U/ml penicillin–streptomycin, and 2 mM L-glutamine.
Generation of the RPE-1 cells carrying centrin-GFP and the tetracy-
cline-inducible system for Plk4 is described in [Ref. 34]. Stable
expression of H2B-EGFP-IRES-mcherry-tubulin was achieved follow-
ing retroviral transduction and isolation of a single clone using fluo-
rescence-activated cell sorting. RPE-1 cells stably expressing EB1-
GFP were a gift from S. Doxsey (UMASS Medical School). HCT-116,
DLD-1, MDA-MB-231, and HT29 were cultured in DMEM with 10%
FBS, 100 U/ml penicillin–streptomycin, and 2 mM L-glutamine.
Tetraploid HCT-116 cells were generated as described in [Ref. 51].
Caco-2 cells were cultured in DMEM with 20% FBS, 100 U/ml peni-
cillin–streptomycin, and 2 mM L-glutamine. 786-O cells were
cultured in RPMI 1640 with 10% FBS, 100 U/ml penicillin–strepto-
mycin, and 2 mM L-glutamine. HT-29, Caco-2, and 786-O cells were
obtained from IRCM Cell Culture Unit, Montpellier.
Generation of DLD-1 IFT88-AID-YFP and derived cell lines
DLD-1 IFT88-AID-YFP cells were generated by adding an auxin-
inducible degron (AID) tag followed by a YFP tag at the 30 end of the
last exon on the IFT88 genomic locus. In detail, DLD-1 Flip-In T-Rex
cells stably expressing TIR1-9xMyc protein [36] were used for the
targeting. sgRNA targeting two regions adjacent to the 30 end of
IFT88 gene were introduced under the control of U6 transcription
promoter into two separated vectors encoding for the expression of
the Cas9 nickase (D10A) [52] (Addgene 42335). A donor construct
containing  600 bp recombination arms surrounding the 30 end of
IFT88 locus, in frame with a sequence encoding for an AID-YFP-Stop
sequence, was generated. All three vectors were transfected into
the DLD-1 Flip-In T-Rex TIR1 cells using X-tremeGENE 9 DNA Trans-
fection Reagent (Roche). Cells were sorted based on their YFP
fluorescence, and single clones were isolated. Homozygous targeted
clones were identified by PCR. Targeting of IFT88 and degradation of
IFT88-AID-YFP were confirmed by Western blot following addition
of auxin (Sigma-Aldrich) at 500 lM in the culture medium for 1 h.
The generation of DLD-1 IFT88-AID-YFP cells expressing stable
inducible hPlk4 was done using hPlk4-YFP cloned into pCDNA5-
frt-TO (gift from A.J. Holland) introduced into the cells via FRT/
Flp-mediated recombination [53]. Cells were transduced with a retro-
viral construct expressing H2B-EGFP-IRES-mcherry-tubulin, and
single clones were isolated using fluorescence-activated cell sorting.
To generate DLD-1 IFT88-AID-YFP cells expressing stable GFP-
HSET, human HSET cDNA (Ultimate ORF clone # IOH4703, Life
Technologies) was cloned into pCDNA5-3xFlag-GFP using the Gate-
way system. GFP-HSET was introduced into the cells via FRT/Flp-
mediated recombination [53] in a unique FRT site and, therefore, is
expressed in an isogenic manner in the cell population.
siRNA and cDNA transfections
Targeted proteins were depleted with small-interfering RNAs
(siRNAs) designed and ordered from Dharmacon. siRNAs sequences
include: non-targeting (siCT): UGGUUUACAUGUCGACUAA (D-00
18110-01); human IFT27: CAGAAAAGCUACACCCUGA (J-009565-
07); human IFT52: UAUCAAAGCGGAAUCGAGA (J-020994-20); and
human IFT88: CGACUAAGUGCCAGACUCAUU [33]. SiRNAs were
delivered to cells at a final concentration of 100 nM using Lipofec-
tamine RNAiMAX (Invitrogen) according to manufacturers’ instruc-
tions. For rescue experiments, mouse IFT52 cDNA transfection was
done with 250 ng pCDNA3-mcherry-IFT52 cDNA using X-treme-
GENE 9 (Roche) according to manufacturers’ instructions.
Antibodies and chemicals
The following primary antibodies were used (Western blot, WB;
immunofluorescence, IF). Proteintech: IFT88 (13967-1-AP; WB:
1/500; IF: 1/250), IFT52 (17534-1-AP; WB: 1/500; IF: 1/500), IFT81
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(11744-1-AP; WB: 1/250), IFT140 (14460-1-AP; WB: 1/500); Novus
Biological: IFT27 (NBP1-87170, WB: 1/200); Sigma-Aldrich: a-
tubulin (T6169, WB: 1/1,000; IF: 1:1,000), FITC-conjugated
a-tubulin (F2168, IF: 1/300), GAPDH (G8795, WB: 1/10,000);
Abcam: a-GFP-FITC (ab6662, IF: 1/500), and HSET/KIFC1
(ab55388, WB: 1/1,000); Cell Signaling Technology: KIFC1/HSET
(12313, IP: 1/100); Millipore: centrin (20H5, IF: 1/5,000); Home-
made: c-tubulin (HM2569, gift from S. Doxsey laboratory [54], IF:
1/500); Homemade: polyglutamylated tubulin (GT-335, gift from C.
Janke Lab [55]) and DAPI (Cell Signaling, IF 1/10,000). Secondary
antibodies include for IF: Alexa Fluor 488-, 568-, or 647-conjugated
anti-rabbit or anti-mouse secondary antibodies (Molecular Probes,
1/1,000), and for WB: anti-mouse and anti-rabbit IgG, HRP-linked
antibody (Cell Signaling, 1/5,000 and 1/10,000, respectively).
The following chemicals were used in the different experiments:
p38 inhibitor at 10 lM (Selleckchem SB302580) to allow for contin-
uous proliferation of RPE-1 cells following centrosome amplification
[20]; nocodazole, 100 ng/ml (Sigma-Aldrich); MG132, 10 lM
(Sigma-Aldrich) HSET inhibitor CW069 at 150 lM with DLD-1 and
25 lM with RPE-1 cells (Selleckchem, S7336); dynein inhibitor
ciliobrevin D, at 50 lM with DLD-1 and 20 lM with RPE-1 cells
(Calbiochem, 250401); APC/C inhibitors ProTAME 10 lM (Boston-
Biochem, I-440) and APCIN 40 lM (BostonBiochem, I-444); doxycy-
cline, 1 lg/ml (Sigma-Aldrich, D9891); and auxin, 500 lM (Sigma-
Aldrich, I5148).
Gel electrophoresis and immunoblotting
Samples were separated by SDS–PAGE, transferred onto PVDF
membrane using Mini Trans-Blot cells (Bio-Rad), and probed over-
night at 4°C using the appropriate antibodies. Western Lightning
Plus-ECL Kit (PerkinElmer) and Blue Devil (Dominique Dutscher)
films were used to reveal the Western blots.
Immunofluorescence
Cells were fixed in 20°C MeOH for immunofluorescence experi-
ments to preserve microtubule staining. Then, cells were blocked
with PBS-BSA 1%-Triton 0.5% and stained for immunofluorescence
with the appropriate primary and secondary antibodies. Slides were
mounted in ProLong Gold (Life Technologies).
Microscopy and image analysis
Epifluorescence images were acquired with a Leica DM6000 Micro-
scope (objective: 63× Plan Apo 1.4 NA) equipped with a CoolSNAP
HQ2 Camera and controlled by MetaMorph (Molecular Devices).
Confocal images were acquired with a Zeiss LSM780 microscope (ob-
jective: 63× Plan Apo 1.4 NA) controlled by ZEN software (Zeiss);
with a spinning disk confocal microscope, a Nikon Ti Eclipse
coupled to a Yokogawa CSU-X1 spinning disk head and an EMCCD
iXon Ultra camera (objectives: 60× Plan Apo 1.4 NA and 100× Plan
Apo 1.45 NA), controlled by the Andor iQ3 software (Andor); or with
a Dragonfly spinning disk microscope (Andor) equipped with iXon
888 Life EMCCD Andor camera (100× Plan Apo 1.45 NA) and
controlled by Fusion software (Andor, Oxford instruments).
Live-cell imaging for quantification of multipolar anaphases was
performed, overnight at 37°C in a CO2-controlled atmosphere, using
an inverted Olympus IX83 microscope equipped with a Zyla 4.2 MP
sCMOS camera (objective: 40× LUCPLFLN 0.6NA RC2, air) and
controlled by MetaMorph (Molecular Devices) on cells seeded in
12-well plates. Images were acquired every 5 min on three plans
with 8-lm Z interval. DNA was visualized with the H2B-EGFP signal
or with SiR-DNA probe (Spirochrome) at 500 nM added 1 h before
imaging begins. Image processing and analysis (cropping, rotating,
brightness, contrast adjustment, color combining, and measure-
ments) were performed using Fiji (ImageJ). Live imaging of centro-
some clustering dynamics was performed, overnight at 37°C in a
CO2-controlled atmosphere, using spinning disk confocal micro-
scope, a Nikon Ti Eclipse coupled to a Yokogawa CSU X1 spinning
disk head and an EMCCD iXon Ultra camera (objective: 40× Plan
Apo 1.3 NA) controlled by the Andor iQ3 software (Andor) on cells
seeded on l-Slide 8 Well (ibiTreat, Ibidi). Images were acquired
every 2 min on 23 plans with 0.5-lm Z interval. DNA was visual-
ized using SiR-DNA probe (Spirochrome) at 500 nM and centro-
somes with centrin-GFP signal. Image segmentation and centrosome
tracking were performed using Imaris (XT module, Bitplane). Indi-
vidual cell drift and rotation were corrected based on the DNA mass
trajectories. Spots were created for each individual centrosome
using the spot-tracking tool, and various parameters on centrosome
spot dynamics were generated using the XT module.
FRAP experiments
FRAP was performed on GFP-HSET, DLD-1 IFT88-AID-YFP cell line.
In the parental cell line (IFT88-AID-YFP without GFP-HSET), no
signal from IFT88-AID-YFP is detectable on the GFP channel under
the FRAP imaging conditions. Cells were seeded 24 h before the
experiment in 96-square well ibiTreat bottom plate (Ibidi). Two
hours before imaging, auxin (500 lM) was added in the correspond-
ing condition. Thirty minutes before imaging, SiR-tubulin Cy5 at
1 lM and verapamil at 10 lM were added to the medium to visual-
ize microtubules according to manufacturer’s instructions (Spiro-
chrome). CW069 at 150 nM (Selleckchem) or DMSO was also added
30 min before imaging on the corresponding conditions. Images
were collected at 37°C with a Zeiss LSM780 confocal microscope
(objective: 63×/1.4 NA DIC Plan Apo). FRAP experiments were
performed using the 488 nm laser line controlled by ZEN software
(Zeiss). Images were acquired on a single plan every 460 ms, and
10 measurements were carried out before the bleaching event. The
bleached zone was a fixed area represented by the green square in
Fig 3I. FRAP analysis was performed, using ImageJ, only in cells
where microtubules remain stable in focus during the acquisition
time in the bleached zone. Background fluorescence was measured
from a zone outside the spindle, and observational photobleaching
was measured from an area equivalent to the FRAP zone in a zone
not submitted to FRAP. Photobleaching and background normaliza-
tion were calculated using Excel software (Microsoft) and applied to
the mean fluorescence intensity values in the FRAP zone.
Clone formation and cell proliferation assays
Cells were treated with siRNA as indicated. The next day, for DLD-1
and HCT-116 cells, 400 cells were seeded in a 10-cm dish, and for
MDA-MB-231, 100 cells were seeded in a 6-well plate. Medium was
replaced every other day. After 14 days, colonies were fixed for 10
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min in methanol and stained for 10min using a crystal violet stain-
ing solution (1% crystal violet and 20% ethanol). For MDA-MB-231
cell proliferation assay, 1 × 105 cells were seeded in a 6-well plate.
The next day, they were treated with siRNA as indicated. Cells were
trypsinized and counted, in duplicate, and re-seeded at the indicated
time points, and cell lysates for Western blots were generated in
parallel, with the same setup, at the same time points.
Recombinant protein purifications, GFP-TRAP pull-down assays,
and immunoprecipitations
Recombinant subcomplex of IFT proteins IFT88/70/52/46 was
expressed in bacteria and purified as described in Ref [42]. FL and
truncated GFP-HSET were expressed in sf9 insect cells and purified
as described in [Ref. 56]. Briefly, full-length N-terminal hexa-
histidine-tagged GFP-HSET, GFP-HSET-tail, and GFP-HSET-motor
cloned in pOET1C-modified vectors (gift of S. Diez, TU Dresden)
were expressed in sf9 insect cells using the flashBAC system (Oxford
Expression Technologies). Cells were harvested, snap-frozen in
liquid nitrogen, and stored at 80°C until purification. Cell pellets
were resuspended in purification buffer (50 mM sodium phosphate
buffer, pH 7.5, 1 mM MgCl2, 10 mM 2-mercaptoethanol, 300 mM
NaCl, 0.1% Tween-20/v, 10% glycerol w/v, 30 mM imidazole, and
EDTA-free protease inhibitors (Roche)). Crude lysate was centri-
fuged at 20,000 g at 4°C and loaded on Ni-NTA resin
(Qiagen). The resin was washed extensively (3 × 1 h) with purifica-
tion buffer containing 30 mM imidazole, plus one wash with
50 mM imidazole. Proteins were eluted in purification buffer
containing 200 mM imidazole, dialyzed overnight against storage
buffer (50 mM Hepes, pH 7.5, 200 mM NaCl, 1 mM MgCl2, DTT
1 mM, MgATP 0.5 mM), aliquoted, snap-frozen in liquid nitrogen,
and stored at 80°C. For GFP pull-down assays with purified HSET
proteins, purified HSET variants were resuspended in pull-down
buffer (80 mM PIPES, 2 mM MgCl2, 1 mM EGTA, 250 mM NaCl,
1 mM DTT, 5% FBS, 1× protease inhibitors (Roche)). 40 lg of
proteins was incubated with 20 ll of GFP-Trap beads (Chromotek),
for 90 min at 4°C and 30 min at RT. They were washed 2 times with
1 ml of pull-down buffer containing 0.2% NP-40. For pull-down of
IFT88/70/52/46, 20 ll of GFP-Trap beads with either FL, tail, or
motor GFP-HSET was incubated with 300 ll of recombinant IFT
proteins for 1 h at RT. Beads were washed five times with 800 ll of
buffer containing 0.2% NP-40 and resuspended in Laemmli buffer
for SDS–PAGE analysis. For pull-down in cell lysate, mitotic
MDA-MB-231 cells were used. Three 15-cm plates of MDA-MB-231
cells at 40% confluency were treated with nocodazole (100 ng/ml)
for 18 h. On the day of the experiment, mitotic-arrested cells were
collected by shake-off. Cell lysate was made by resuspending
1 × 107 cells in 500 ll of lysis buffer (50 mM Hepes, pH 7.5,
150 mM NaCl, 1.5 mM MgCl2, 1 mM EGTA, 1× protease inhibitor
(Roche), 0.5% NP-40) incubated for 30 min at 4°C with frequent
pipetting. Lysate was spun 10 min at 21,000 g. Clear lysate was
adjusted to 0.2% NP-40 with lysis buffer without NP-40. GFP-Trap
with the GFP-HSET constructs were incubated with 300 ll of cell
lysate for 1 h at RT, washed five times with 800 ll of buffer contain-
ing 0.2% NP-40, and resuspended in Laemmli buffer for SDS–PAGE
analysis. For endogenous immunoprecipitations, MDA-MB-231 cell
lysate was prepared as for GFP pull-down assay. Rabbit IgG or
KIFC1/HSET antibody (Cell Signaling Technology, ref. #12313) was
added to the cell lysate and incubated overnight at 4°C. Lysates
were then incubated for 1 h with protein G-PLUS agarose beads
(Santa Cruz; sc-2002). Beads were washed four times with 500 ll
lysis buffer containing 0.2% NP-40, and the immunoprecipitated
proteins were separated by SDS–PAGE and analyzed by
Western blotting.
Statistical analysis
The number of cells counted per experiment for statistical analysis
is indicated in figure legends. Graphs were created using GraphPad
Prism software. P-values were calculated using two-tailed
Student’s t-tests.
Expanded View for this article is available online.
Acknowledgements
The experiments were performed on the imaging platform Montpellier
Ressources Imagerie (MRI), Montpellier, member of the national infrastructure
France-BioImaging supported by the French National Research Agency (ANR-
10-INSB-04, “Investments for the future”). We particularly thank S. De Rossi
for his assistance regarding image analysis, M. Boyer for her help with cytome-
try, and C. Hassen-Kodja for his help with data analysis. We thank the Mont-
pellier Genomic Collection Platform (S. Fromont and F. Lionneton). We would
like to thank D. Xirodimas for critical reading of the manuscript. We also thank
A. Holland, D. Fachinetti, S. Diez, S. Doxsey, and C. Janke for reagents and
advice. We thank the IRCM Cell Culture Unit (Grant INCa-DGOS-Inserm 6045)
for cancer cell lines. This work was supported by Projet Fondation ARC grants
(PJA 20151203324 and PJA 20171206441 to BV), ANR JCJC IRMM grant (ANR-
18-CE11-0025-01 to BV), ANR “Chaire d’excellence” CilMitoCyst grant (ANR-12-
CHEX-005 to BD), the Marie Curie Career Integration Grant (CilMitoPatho to
B.D.), the Fondation pour la Recherche Médicale (Partenariat Fondation
Schlumberger pour l’Education et la Recherche to B.D.) and the CNRS (BV, CA,
and BD).
Author contributions
BV, NT, AG, ADou, ADos, MC, JM, SH, and CA conducted the experiments and
analyzed the experimental work. MT and EL generated the recombinant IFT
proteins. BV and BD conceived, designed, and supervised the project. BV and
BD assembled the figures and wrote the manuscript.
Conflict of interest
The authors declare that they have no conflict of interest.
References
1. Nigg EA, Raff JW (2009) Review centrioles, centrosomes, and cilia in
health and disease. Cell 1: 663 – 678
2. Tang N, Marshall WF (2012) Centrosome positioning in vertebrate devel-
opment. J Cell Sci 125: 4951 – 4961
3. Nigg EA, Holland AJ (2018) Once and only once: mechanisms of centriole
duplication and their deregulation in diseases. Nat Rev Mol Cell Biol 19:
297 – 312
4. Ganem NJ, Godinho SA, Pellman D (2009) A mechanism linking extra
centrosomes to chromosomal instability. Nature 460: 278 – 282
5. Silkworth WT, Nardi IK, Scholl LM, Cimini D (2009) Multipolar spindle
pole coalescence is a major source of kinetochore mis-attachment and
chromosome mis-segregation in cancer cells. PLoS ONE 4: e6564
ª 2020 The Authors EMBO reports 21: e49234 | 2020 13 of 15
Benjamin Vitre et al EMBO reports
6. Vitre BD, Cleveland DW (2012) Centrosomes, chromosome instability
(CIN) and aneuploidy. Curr Opin Cell Biol 24: 809 – 815
7. Kulukian A, Holland AJ, Vitre B, Naika S, Cleveland DW, Fuchs E (2015)
Epidermal development, growth control, and homeostasis in the face of
centrosome amplification. Proc Natl Acad Sci USA 112: E6311 – E6320
8. Vitre B, Holland AJ, Kulukian A, Shoshani O, Hirai M, Wang Y, Maldonado
M, Cho T, Boubaker J, Swing DA et al (2015) Chronic centrosome amplifi-
cation without tumorigenesis. Proc Natl Acad Sci USA 112: E6321 – E6330
9. Basto R, Brunk K, Vinadogrova T, Peel N, Franz A, Khodjakov A, Raff JW
(2008) Centrosome amplification can initiate tumorigenesis in flies. Cell
133: 1032 – 1042
10. Coelho PA, Bury L, Shahbazi MN, Liakath-Ali K, Tate PH, Wormald S,
Hindley CJ, Huch M, Archer J, Skarnes WC et al (2015) Over-expression
of Plk4 induces centrosome amplification, loss of primary cilia and asso-
ciated tissue hyperplasia in the mouse. Open Biol 5: 150209
11. Serçin Ö, Larsimont J-C, Karambelas AE, Marthiens V, Moers V, Boeckx B,
Le Mercier M, Lambrechts D, Basto R, Blanpain C (2015) Transient PLK4
overexpression accelerates tumorigenesis in p53-deficient epidermis. Nat
Cell Biol 18: 100 – 110
12. Levine MS, Bakker B, Boeckx B, Moyett J, Lu J, Vitre B, Spierings DC, Lans-
dorp PM, Cleveland DW, Lambrechts D et al (2017) Centrosome amplifi-
cation is sufficient to promote spontaneous tumorigenesis in mammals.
Dev Cell 40: 313 – 322.e5
13. Kwon M, Godinho SA, Chandhok NS, Ganem NJ, Azioune A, Thery M,
Pellman D (2008) Mechanisms to suppress multipolar divisions in cancer
cells with extra centrosomes. Genes Dev 22: 2189 – 2203
14. Marthiens V, Rujano MA, Pennetier C, Tessier S, Paul-Gilloteaux P, Basto
R (2013) Centrosome amplification causes microcephaly. Nat Cell Biol
15: 731 – 740
15. Dzafic E, Strzyz PJ, Wilsch-Bräuninger M, Norden C (2015) Centriole
amplification in zebrafish affects proliferation and survival but not dif-
ferentiation of neural progenitor cells. Cell Rep 13: 168 – 182
16. Levine MS, Holland AJ (2018) The impact of mitotic errors on cell prolif-
eration and tumorigenesis. Genes Dev 32: 620 – 638
17. Quintyne N, Reing J, Hoffelder D, Gollin S, Saunders WS (2005) Spindle
multipolarity is prevented by centrosomal clustering. Science 307: 127
18. Leber B, Maier B, Fuchs F, Chi J, Riffel P, Anderhub S, Wagner L, Ho AD,
Salisbury JL, Boutros M et al (2010) Proteins required for centrosome
clustering in cancer cells. Sci Transl Med 2: 33ra38
19. Chavali PL, Chandrasekaran G, Barr AR, Tátrai P, Taylor C, Papachristou
EK, Woods CG, Chavali S, Gergely F (2016) A CEP215-HSET complex links
centrosomes with spindle poles and drives centrosome clustering in
cancer. Nat Commun 7: 11005
20. Rhys AD, Monteiro P, Smith C, Vaghela M, Arnandis T, Kato T, Leitinger
B, Sahai E, McAinsh A, Charras G et al (2018) Loss of E-cadherin
provides tolerance to centrosome amplification in epithelial cancer cells.
J Cell Biol 217: 195 – 209
21. Patel N, Weekes D, Drosopoulos K, Gazinska P, Noel E, Rashid M, Mirza
H, Quist J, Brasó-Maristany F, Mathew S et al (2018) Integrated geno-
mics and functional validation identifies malignant cell specific depen-
dencies in triple negative breast cancer. Nat Commun 9 – 1044
22. Kozminski KG, Johnson KA, Forscher P, Rosenbaum JL (1993) A motility in
the eukaryotic flagellum unrelated to flagellar beating. Proc Natl Acad
Sci USA 90: 5519 – 5523
23. Rosenbaum JL, Witman GB (2002) Intraflagellar transport. Nat Rev Mol
Cell Biol 3: 813 – 825
24. Lechtreck KF (2015) IFT-cargo interactions and protein transport in cilia.
Trends Biochem Sci 40: 765 – 778
25. Taschner M, Kotsis F, Braeuer P, Kuehn EW, Lorentzen E (2014) Crystal
structures of IFT70/52 and IFT52/46 provide insight into intraflagellar
transport B core complex assembly. J Cell Biol 207: 269 – 282
26. Taschner M, Lorentzen E (2016) The intraflagellar transport machinery.
Cold Spring Harb Perspect Biol 8: a028092 – 20
27. Finetti F, Paccani SR, Riparbelli MG, Giacomello E, Perinetti G, Pazour GJ,
Rosenbaum JL, Baldari CT (2009) Intraflagellar transport is required for
polarized recycling of the TCR/CD3 complex to the immune synapse. Nat
Cell Biol 11: 1332 – 1339
28. Bizet AA, Becker-Heck A, Ryan R, Weber K, Filhol E, Krug P, Halbritter J,
Delous M, Lasbennes M-C, Linghu B et al (2015) Mutations in TRAF3IP1/
IFT54 reveal a new role for IFT proteins in microtubule stabilization. Nat
Commun 6: 8666
29. Boehlke C, Janusch H, Hamann C, Powelske C, Mergen M, Herbst H,
Kotsis F, Nitschke R, Kuehn EW (2015) A cilia independent role of Ift88/
Polaris during cell migration. PLoS ONE 10: e0140378 – e0140378
30. Dupont MA, Humbert C, Huber C, Siour Q, Guerrera IC, Jung V, Chris-
tensen A, Pouliet A, Garfa-Traoré M, Nitschké P et al (2019) Human
IFT52 mutations uncover a novel role for the protein in microtubule
dynamics and centrosome cohesion. Hum Mol Genet 28: 2720 – 2737
31. Taulet N, Douanier A, Vitre B, Anguille C, Maurin J, Dromard Y, Georget
V, Delaval B (2019) IFT88 controls NuMA enrichment at k-fibers minus-
ends to facilitate their re-anchoring into mitotic spindles. Sci Rep 9:
10311
32. Taulet N, Vitre B, Anguille C, Douanier A, Rocancourt M, Taschner M,
Lorentzen E, Echard A, Delaval B (2017) IFT proteins spatially control the
geometry of cleavage furrow ingression and lumen positioning. Nat
Commun 8: 1928
33. Delaval B, Bright A, Lawson ND, Doxsey S (2011) The cilia protein IFT88
is required for spindle orientation in mitosis. Nat Cell Biol 13: 461 – 468
34. Wang WJ, Soni RK, Uryu K, Bryan Tsou MF (2011) The conversion of
centrioles to centrosomes: essential coupling of duplication with segre-
gation. J Cell Biol 193: 727 – 739
35. Nishimura K, Fukagawa T, Takisawa H, Kakimoto T, Kanemaki M (2009)
An auxin-based degron system for the rapid depletion of proteins in
nonplant cells. Nat Methods 6: 917 – 922
36. Holland AJ, Fachinetti D, Han JS, Cleveland DW (2012) Inducible, rever-
sible system for the rapid and complete degradation of proteins in
mammalian cells. Proc Natl Acad Sci USA 109: E3350 – E3357
37. Mohamed MAA, Stepp WL, Ökten Z (2018) Reconstitution reveals motor
activation for intraflagellar transport. Nature 557: 387 – 391
38. Firestone AJ, Weinger JS, Maldonado M, Barlan K, Langston LD, O’Donnell
M, Gelfand VI, Kapoor TM, Chen JK (2012) Small-molecule inhibitors of
the AAA+ ATPase motor cytoplasmic dynein. Nature 484: 125 – 129
39. Watts CA, Richards FM, Bender A, Bond PJ, Korb O, Kern O, Riddick M,
Owen P, Myers RM, Raff J et al (2013) Design, synthesis, and biological
evaluation of an allosteric inhibitor of HSET that targets cancer cells
with supernumerary centrosomes. Chem Biol 20: 1399 – 1410
40. Sackton KL, Dimova N, Zeng X, Tian W, Zhang M, Sackton TB, Meaders J,
Pfaff KL, Sigoillot F, Yu H et al (2014) Synergistic blockade of mitotic
exit by two chemical inhibitors of the APC/C. Nature 514: 646 – 649
41. Lancaster MA, Schroth J, Gleeson JG (2011) Subcellular spatial regulation
of canonical Wnt signalling at the primary cilium. Nat Cell Biol 13:
700 – 708
42. Taschner M, Bhogaraju S, Vetter M, Morawetz M, Lorentzen E (2011)
Biochemical mapping of interactions within the intraflagellar transport
(IFT) B core complex: IFT52 binds directly to four other IFT-B subunits.
J Biol Chem 286: 26344 – 26352
14 of 15 EMBO reports 21: e49234 | 2020 ª 2020 The Authors
EMBO reports Benjamin Vitre et al
43. Splinter D, Tanenbaum ME, Lindqvist A, Jaarsma D, Flotho A, Lou Y,
Grigoriev I, Engelsma D, Haasdijk ED, Keijzer N et al (2010) Bicaudal D2,
dynein, and kinesin-1 associate with nuclear pore complexes and regu-
late centrosome and nuclear positioning during mitotic entry. PLoS Biol
8: e1000350 – 20
44. Bolhy S, Bouhlel I, Dultz E, Nayak T, Zuccolo M, Gatti X, Vallee R, Ellen-
berg J, Doye V (2011) A Nup133-dependent NPC-anchored network teth-
ers centrosomes to the nuclear envelope in prophase. J Cell Biol 192:
855 – 871
45. Endres NF, Yoshioka C, Milligan RA, Vale RD (2006) A lever-arm rotation
drives motility of the minus-end-directed kinesin Ncd. Nature 439:
875 – 878
46. Zhang P, Dai W, Hahn J, Gilbert SP (2015) Drosophila Ncd reveals an
evolutionarily conserved powerstroke mechanism for homodimeric and
heterodimeric kinesin-14s. Proc Natl Acad Sci USA 112: 6359 – 6364
47. Nitzsche B, Dudek E, Hajdo L, Kasprzak AA, Vilfan A, Diez S (2016) Work-
ing stroke of the kinesin-14, ncd, comprises two substeps of different
direction. Proc Natl Acad Sci USA 113: E6582 – E6589
48. Verhey KJ, Hammond JW (2009) Cytoskeletal motors: traffic control:
regulation of kinesin motors. Nat Rev Mol Cell Biol 10: 765 – 777
49. Blasius TL, Cai D, Jih GT, Toret CP, Verhey KJ (2007) Two binding
partners cooperate to activate the molecular motor Kinesin-1. J Cell Biol
176: 11 – 17
50. Vinogradova MV, Malanina GG, Reddy ASN, Fletterick RJ (2009) Structure
of the complex of a mitotic kinesin with its calcium binding regulator.
Proc Natl Acad Sci USA 106: 8175 – 8179
51. Castedo M, Coquelle A, Vivet S, Vitale I, Kauffmann A, Dessen P, Pequig-
not MO, Casares N, Valent A, Mouhamad S et al (2006) Apoptosis regu-
lation in tetraploid cancer cells. EMBO J 25: 2584 – 2595
52. Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, Hsu PD, Wu X, Jiang
W, Marraffini LA et al (2013) Multiplex genome engineering using
CRISPR/Cas systems. Science 339: 819 – 823
53. Tighe A, Johnson VL, Taylor SS (2004) Truncating APC mutations have
dominant effects on proliferation, spindle checkpoint control, survival
and chromosome stability. J Cell Sci 117: 6339 – 6353
54. Delaval B, Covassin L, Lawson ND, Doxsey S (2011) Centrin depletion
causes cyst formation and other ciliopathy-related phenotypes in zebra-
fish. Cell Cycle 10: 3964 – 3972
55. Wolff A, de Néchaud B, Chillet D, Mazarguil H, Desbruyères E, Audebert
S, Eddé B, Gros F, Denoulet P (1992) Distribution of glutamylated alpha
and beta-tubulin in mouse tissues using a specific monoclonal antibody,
GT335. Eur J Cell Biol 59: 425 – 432
56. Braun M, Lansky Z, Szuba A, Schwarz FW, Mitra A, Gao M, Lüdecke A,
Ten Wolde PR, Diez S (2017) Changes in microtubule overlap length
regulate kinesin-14-driven microtubule sliding. Nat Chem Biol 13:
1245 – 1252
License: This is an open access article under the
terms of the Creative Commons Attribution 4.0
License, which permits use, distribution and reproduc-
tion in any medium, provided the original work is
properly cited.
Benjamin Vitre et al EMBO reports
ª 2020 The Authors EMBO reports 21: e49234 | 2020 15 of 15
